This site is intended for Healthcare professionals only.
×

Sun Pharma, Moebius Medical ink pact to develop pain product


Sun Pharma, Moebius Medical ink pact to develop pain product

Sun Pharmaceutical Industries and Israel-based Moebius Medical have signed a global licensing pact to develop further an injection for treating osteoarthritis pain.

The exclusive worldwide licensing deal is to further develop MM-II, a novel non-opioid pain product for osteoarthritis, the companies said in a joint statement.

Spread the love


Source: PTI
0 comment(s) on Sun Pharma, Moebius Medical ink pact to develop pain product

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted